1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D9B261191850AD36002586FE000564A2
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew?OpenForm&Query=(alliance%20and%20partnership)%20and%20(field%20ItemCatalog%3DBMR)&SearchWV=1&AQ%3Dalliance%20and%20partnership&ItemCatalog=BMR&SearchOrder=1&Start=21&Count=10
18
19OpenForm&Query=(alliance%20and%20partnership)%20and%20(field%20ItemCatalog%3DBMR)&SearchWV=1&AQ%3Dalliance%20and%20partnership&ItemCatalog=BMR&SearchOrder=1&Start=21&Count=10
203.236.170.171
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Search Results

Results 21 - 30 of 51 Total Hits, Sorted by Relevance.

    |    

Patient Advocacy: How Top Pharma Companies Partner with Advocacy Groups to Shape Policy, Improve Access, and Boost Patient VoiceDirect access to this research is not included with your membership level.

As pharma manufacturers embrace new tools and approaches to become more patient-centric, their relationships with advocacy groups have never been more important or impactful... (ID PSM-353)
Companies Profiled: AbbVie, Acceleron Pharma, Agendia, Alnylam Pharmaceuticals, more ...

Patient Advocacy: How Top Pharma Companies Partner with Advocacy Groups to Shape Policy, Improve Access, and Boost Patient Voice Outside of the United StatesDirect access to this research is not included with your membership level.

As the pharmaceutical industry gravitates toward a patient centric model, the importance of establishing meaningful relationships with advocacy groups has never been greater for organizations... (ID PSM-357)
Companies Profiled: AbbVie, Astellas, Bayer, BioMarin, more ...

Patient Advocacy: How Top Pharma Companies Partner with Advocacy Groups to Shape Policy, Improve Access, and Boost Patient Voice in the United StatesDirect access to this research is not included with your membership level.

As treatment options in the United States become more complex and plentiful, pharmaceutical manufacturers are increasingly relying on their relations... (ID PSM-356)
Companies Profiled: Acceleron Pharma, Agendia, Alnylam Pharmaceuticals, Amicus Therapeutics, more ...

Top Management Tactics & Long-Term Strategies for Senior Biopharma Executives Steering through COVID-19 and BeyondDirect access to this research is not included with your membership level.

Biopharma organizations - and the strategies of their senior leaders - must evolve to meet short-term threats and long-term challenges arising out of the COVID-19 health and economic crisis... (ID CM-5)
Companies Profiled: Almirall, Apellis Pharmaceuticals, Astellas, Biofrontera, more ...

Innovations in Patient-Focused Initiatives: Case Studies in Reaching, Engaging and Supporting PatientsDirect access to this research is not included with your membership level.

With so much riding on the consumers’ acceptance of a product, it is only logical to have in place initiatives that focus on the unfulfilled needs of... (ID PSM-239)
Companies Profiled: Acorda Therapeutics, Sanofi-aventis, Amgen, Bayer, more ...

Trends and Future Directions for the High Performing District Sales Manager: A Comparative View from 2007 and 2009Direct access to this research is not included with your membership level.

The district sales manager (DM) is the cornerstone of sales force effectiveness and high performance... (ID PSM-247)
Companies Profiled: Actelion, Schering-Plough, Sanofi-aventis, Shire, more ...

Winning Brand Team Management: Best Practices in Leadership, Work Practices, Structure and Performance ManagementDirect access to this research is not included with your membership level.

The driving force behind revenue in biotechnology and pharmaceutical companies is the product... (ID SM-177)
Companies Profiled: Abbott, Takeda Pharmaceuticals, Stiefel, Shire, more ...

Probing Best Practices for Successful Primary Care Launch & Physician EngagementDirect access to this research is not included with your membership level.

Maximizing a new biopharma product launch often requires a distinct and comprehensive primary care strategy, where innovative physician targeting and... (ID PSM-372)
Companies Profiled: Abbott Laboratories, Abbvie, Actavis, Actelion, more ...

Best Practices Pharma Launch PlaybookDirect access to this research is not included with your membership level.

The pharmaceutical launch paradigm has evolved over the years, and with it has risen the complexity of orchestrating a successful new product launch... (ID PB-100)
Companies Profiled: Abbott, AbbVie, actavis, Actelion, more ...

Strategic Portfolio Planning for Successful New Product and Drug Platform PositioningDirect access to this research is not included with your membership level.

As indications become more crowded, and the needs and influence of key stakeholders evolve, pharmaceutical and biotech companies need to meticulously... (ID PSM-365)
Companies Profiled: Abbott, AbbVie, Actelion, Adamas Pharmaceuticals, more ...